HCPCS Level IIdrugActive
J9256
Inj, nipocalimab-aahu, 3 mg
BETOS: O1E
Effective: 2026-01-01
Description
Injection, nipocalimab-aahu, 3 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Imaavy
Manufacturer
Janssen Biotech, Inc.
HCPCS Dosage
3 MG
Billing Units
100.0000
2
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.